INTERNATIONAL STEM CELL CORPORATION — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-11.9% -$291K
$2M
Cost of Revenue↑+7.7% +$76K
$1M
R&D↓-15.7% -$33K
$177K
D&A↑+0.0% +$0
$54K
Operating Income↑+204.4% +$184K
$94K
EBITDA↓-28.9% -$22K
$54K
Interest Expense↓-10.3% -$4K
$35K
Other Income/Expense
—
Pretax Income
—
Tax Provision
$0
Net Income↑+145.6% +$182K
$57K
Operating Margin↑+8.1pts
4.0%
Net Margin↑+8.1pts
2.4%
Effective Tax Rate
—
Tax Credit Carryforwards
$0
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
-10.6%
ETR Foreign Differential (pp)
-70.8%
Operating Lease Cost↑+41.2% +$28K
$96K
Revenue YoY Variation↓-41.4pts
-11.9%
Income YoY Variation↑+197.2pts
204.4%
Revenue QoQ Variation↓-21.3pts
-9.0%
Income QoQ Variation↑+116.7pts
-43.7%